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Introduction: Premature infants face multiple challenges including periventricular leuko-
malacia (PVL) and successful therapies are lacking. Oligodendrocyte Progenitor Cells (OPCs) 
give rise to myelin producing cells during brain development. Activation of dormant OPCs 
at the epigenetic level represents an attractive strategy. Long non-coding RNA H19 is a po-
tential candidate to regulate epigenetic cell differentiation since it inhibits S-adenosylme-
thionine-dependent methyltransferases that methylate DNA at regulatory sites. Since syn-
thetic PreImplantation factor (sPIF) protects against multiple neuronal disorders, we posit 
that sPIF activates OPCs by tuning gene methylation dynamics through H19. 
Methods: Cell lines (OPCs MO13.13) were treated with sPIF (200nM; 48h), and downstream 
differentiation markers were evaluated by quantitative RT-PCR. H19 loss and gain of func-
tion studies and genome-wide methylation profiling were performed. Two-tailed Student’s 
t-test and Mann- Whitney tests were used in analysis with level of significance set at p <0.05.
Results: Both sPIF and the overexpression of H19 enhanced oligodendrocyte differentia-
tion. In MO13.13s, sPIF increased mRNA expression of immature (OLIG2) and mature (MBP) 
oligodendrocyte markers in H19-dependent manner. Genome-wide methylation profiling 
reveals that H19 overexpression significantly de - methylated intron regions of the gene lo-
cus of NCOR2, a key regulatory cellular factor, leading to an increased expression. NCOR2 en-
hanced oligodendrocyte differentiation and OPCs knockdown for NCOR2, subjected to sPIF, 
were not able to differentiate. 
Conclusion: sPIF activates OPCs and boosters myelin production by modulating H19 and 
the de-methylation of NCOR2 of the OPCs. Our results uncover an unanticipated regulatory 
circuit of sPIF involving broad epigenetic alterations by a single lncRNA that may under-
lie gene methylation dynamics of development and diseases. Given the FDA Fast Track de-
signation and safety data of sPIF in First in Human Clinical Trial (ClinicalTrials.gov Identifier: 
NCT02239562), clinical trials to prevent or treat PVL can be envisioned.
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